In pancreatic cancer, long-term exposure to 5-HT in an autocrine or paracrine manner induced PRC2-independent EZH2 action that supported the TPH1-5-HT7 axis, leading to gemcitabine resistance and a CSC population increase. This evidence concerns the gene EZH2 and pancreatic neoplasm.